Standard BioTools Inc.
LAB | NASDAQ
$0.74
-$0.03 (-3.87%)
At close: Sep 21, 2026, 4:00 PM ET
$0.73
-$0.01 (-1.35%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 84.6M | 86.26M | 85.33M | 108.25M | 133.67M | 134.4M | 159.72M | 141.19M | 121.59M | 126.76M | 106.34M | 105.17M | 105.45M | 96.56M | 97.95M | 109.19M | 112.05M | 124.29M | 130.58M | 136.92M | 148.28M | 143.32M |
Cost of Revenue | 43.03M | 44.6M | 43.93M | 55.19M | 66.83M | 67.81M | 79.99M | 70.01M | 62.51M | 64.46M | 55.95M | 56.97M | 59.18M | 59.47M | 60.9M | 63.07M | 61.48M | 61.72M | 61.21M | 61.58M | 61.28M | 57.41M |
Gross Profit | 41.57M | 41.66M | 41.4M | 53.07M | 66.84M | 66.59M | 79.73M | 71.18M | 59.07M | 62.3M | 50.39M | 48.2M | 46.27M | 37.1M | 37.05M | 46.13M | 50.58M | 62.57M | 69.37M | 75.35M | 87M | 85.92M |
Operating Income | -80.2M | -78.51M | -93.31M | -104.2M | -112.45M | -119.01M | -154.98M | -143.55M | -133M | -120.19M | -76.6M | -76.33M | -84.18M | -105.3M | -116.21M | -106.35M | -96.94M | -75.64M | -67.46M | -73.1M | -58.96M | -55.41M |
Interest Income | 7.31M | 9.77M | 9.18M | 7.52M | 9.32M | 12.16M | 15.45M | 15.45M | 11.51M | 6.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -90.98M | -87.83M | -96.7M | -108.47M | -102.39M | -109.51M | -118.05M | -104.19M | -98.32M | -89.65M | -74.2M | -75.04M | -84.23M | -132.65M | -192.93M | -182.4M | -167.52M | -120.03M | -63.66M | -70.46M | -61.43M | -57.93M |
Net Income | -87.38M | -94.08M | -74.9M | -128.25M | -120.5M | -132.76M | -138.89M | -124.59M | -118.65M | -89.97M | -74.66M | -75.73M | -84.15M | -130.65M | -190.1M | -178.68M | -163.1M | -116.7M | -59.24M | -67.83M | -59.99M | -55.86M |
Selling & General & Admin | 85.97M | 97.69M | 108.9M | 122.11M | 129.92M | 126.68M | 143.79M | 127.56M | 115.45M | 113.19M | 87.54M | 90.09M | 94.14M | 101.62M | 111.2M | 110.26M | 107.99M | 102.16M | 98.89M | 107.86M | 106.45M | 102.81M |
Research & Development | 18.23M | 22.48M | 25.8M | 32.07M | 38.87M | 39.89M | 50.43M | 43.29M | 36.5M | 35.44M | 25.89M | 27.36M | 29.48M | 35.9M | 38.33M | 38.5M | 39.22M | 36.06M | 37.94M | 40.59M | 39.51M | 38.52M |
Other Expenses | 17.56M | n/a | n/a | 3.08M | 10.5M | 19.03M | 40.48M | 43.88M | 40.12M | 33.86M | 13.56M | 7.08M | 6.84M | 4.87M | 3.72M | 3.72M | 300K | n/a | n/a | n/a | 107K | 107K |
Operating Expenses | 121.76M | 120.17M | 134.71M | 157.26M | 179.29M | 185.6M | 234.71M | 214.73M | 192.07M | 182.49M | 126.99M | 124.53M | 130.45M | 142.39M | 153.26M | 152.48M | 147.51M | 138.21M | 136.83M | 148.45M | 145.95M | 141.33M |
Interest Expense | 15K | 24K | 26K | 21K | 11K | 860K | 1.89M | 2.99M | 4.21M | 4.48M | 4.57M | 4.66M | 4.49M | 4.42M | 4.33M | 4.21M | 4.13M | 3.97M | 3.82M | 3.64M | 3.56M | 3.56M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 164.79M | 164.76M | 178.64M | 212.45M | 246.12M | 253.41M | 314.7M | 284.74M | 254.59M | 246.95M | 182.94M | 181.5M | 189.63M | 201.86M | 214.15M | 215.54M | 208.99M | 199.93M | 198.04M | 210.03M | 207.24M | 198.74M |
Income Tax Expense | -37.05M | -37.75M | -37.88M | -1.67M | -338K | 310K | 557K | 123K | 55K | 317K | 452K | 684K | -79K | -1.99M | -2.83M | -3.71M | -4.42M | -3.33M | -4.42M | -2.62M | -1.44M | -2.07M |
Shares Outstanding (Basic) | 390.88M | 388.2M | 385.05M | 382.63M | 380.5M | 378.23M | 374.54M | 371.54M | 372.33M | 294.13M | 79.73M | 79.15M | 78.67M | 79.08M | 79.43M | 78.9M | 77.82M | 77.03M | 76.65M | 76.3M | 75.45M | 74.71M |
Shares Outstanding (Diluted) | 390.88M | 388.2M | 385.05M | 382.63M | 380.5M | 378.23M | 374.54M | 371.54M | 372.33M | 294.13M | 79.73M | 79.15M | 78.67M | 79.08M | 79.43M | 78.9M | 77.82M | 77.03M | 76.65M | 76.3M | 75.45M | 74.71M |
EPS (Basic) | -0.23 | -0.25 | -0.20 | -0.34 | -0.32 | -0.35 | -0.55 | -0.71 | -0.91 | -1.01 | -0.95 | -0.96 | -1.06 | -1.66 | -2.44 | -2.30 | -2.11 | -1.52 | -0.78 | -0.90 | -0.80 | -0.75 |
EPS (Diluted) | -0.23 | -0.25 | -0.20 | -0.34 | -0.32 | -0.35 | -0.55 | -0.71 | -0.91 | -1.01 | -0.95 | -0.96 | -1.06 | -1.66 | -2.44 | -2.30 | -2.11 | -1.52 | -0.78 | -0.90 | -0.80 | -0.75 |
EBITDA | -91.9M | -81.51M | -87.62M | -92.9M | -82.05M | -86.47M | -92.96M | -81.87M | -74.95M | -65.81M | -51.79M | -52.83M | -64.79M | -113.49M | -173.57M | -162.89M | -147.83M | -100.44M | -44.27M | -51.12M | -42.09M | -38.59M |
EBIT | -98.87M | -87.8M | -96.68M | -104.63M | -96.03M | -102.31M | -109.82M | -98.68M | -91.89M | -82.53M | -66.97M | -67.72M | -79.3M | -128.21M | -188.6M | -178.18M | -163.39M | -116.06M | -59.84M | -66.82M | -57.88M | -54.37M |
Depreciation & Amortization | 6.97M | 6.29M | 9.06M | 11.72M | 13.98M | 15.84M | 16.86M | 16.81M | 16.94M | 16.71M | 15.18M | 14.89M | 14.51M | 14.72M | 15.03M | 15.29M | 15.56M | 15.63M | 15.57M | 15.7M | 15.79M | 15.78M |
Add to Watchlist
Select watchlists to add or remove LAB